Published in Core Evid on June 15, 2010
Stratified approaches to the treatment of asthma. Br J Clin Pharmacol (2013) 0.98
A repeat-dose thorough QT study of inhaled fluticasone furoate/vilanterol combination in healthy subjects. Br J Clin Pharmacol (2014) 0.86
Indacaterol in chronic obstructive pulmonary disease: an update for clinicians. Ther Adv Chronic Dis (2012) 0.78
Indacaterol (arcapta neohaler) for chronic obstructive pulmonary disease. P T (2012) 0.76
The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest (2006) 8.43
Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J (2008) 5.38
Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD. Thorax (2003) 4.53
Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium. Eur Respir J (2002) 3.66
Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J (2004) 3.19
Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD. Chest (2005) 2.15
Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease. Eur Respir J (2004) 1.98
Is there a problem with inhaled long-acting beta-adrenergic agonists? J Allergy Clin Immunol (2006) 1.72
In vitro and in vivo pharmacological characterization of 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one (indacaterol), a novel inhaled beta(2) adrenoceptor agonist with a 24-h duration of action. J Pharmacol Exp Ther (2006) 1.42
Safety, tolerability and efficacy of indacaterol, a novel once-daily beta(2)-agonist, in patients with COPD: a 28-day randomised, placebo controlled clinical trial. Pulm Pharmacol Ther (2006) 1.30
A dose-ranging study of indacaterol in obstructive airways disease, with a tiotropium comparison. Respir Med (2008) 1.21
Effect of indacaterol, a novel long-acting beta2-agonist, on isolated human bronchi. Eur Respir J (2006) 1.16
Pharmacological characterization of indacaterol, a novel once daily inhaled 2 adrenoceptor agonist, on small airways in human and rat precision-cut lung slices. J Pharmacol Exp Ther (2007) 1.06
Indacaterol, a novel inhaled beta2-agonist, provides sustained 24-h bronchodilation in asthma. Eur Respir J (2007) 1.05
Comparison of the effects of salmeterol and formoterol on airway tone and responsiveness over 24 hours in bronchial asthma. Am Rev Respir Dis (1993) 1.03
Indacaterol provides sustained 24 h bronchodilation on once-daily dosing in asthma: a 7-day dose-ranging study. Allergy (2008) 0.95
Once-daily inhaled corticosteroids in mild to moderate asthma: improving acceptance of treatment. Drugs (1999) 0.90
Safety and tolerability of indacaterol in asthma: a randomized, placebo-controlled 28-day study. Respir Med (2007) 0.89
Tolerability of indacaterol, a novel once-daily beta2-agonist, in patients with asthma: a randomized, placebo-controlled, 28-day safety study. Ann Allergy Asthma Immunol (2007) 0.85
Efficacy and safety of single therapeutic and supratherapeutic doses of indacaterol versus salmeterol and salbutamol in patients with asthma. Curr Med Res Opin (2007) 0.84
Bronchodilator efficacy of indacaterol, a novel once-daily beta2-agonist, in patients with persistent asthma. Ann Allergy Asthma Immunol (2008) 0.84
A blinded evaluation of the efficacy and safety of glycopyrronium, a once-daily long-acting muscarinic antagonist, versus tiotropium, in patients with COPD: the GLOW5 study. BMC Pulm Med (2014) 1.21
The short, the long and the "ultra-long": why duration of bronchodilator action matters in chronic obstructive pulmonary disease. Adv Ther (2010) 1.07
Long-term repeatability of induced sputum cells and inflammatory markers in stable, moderately severe COPD. Chest (2003) 1.03
Bimosiamose, an inhaled small-molecule pan-selectin antagonist, attenuates late asthmatic reactions following allergen challenge in mild asthmatics: a randomized, double-blind, placebo-controlled clinical cross-over-trial. Pulm Pharmacol Ther (2005) 1.01
Clinical application of a simple questionnaire for the differentiation of asthma and chronic obstructive pulmonary disease. Respir Med (2004) 0.99
Clinical trial design in chronic obstructive pulmonary disease: current perspectives and considerations with regard to blinding of tiotropium. Respir Res (2012) 0.87
Increased glutathione disulfide and nitrosothiols in sputum supernatant of patients with stable COPD. Chest (2004) 0.86
Tolerability of indacaterol, a novel once-daily beta2-agonist, in patients with asthma: a randomized, placebo-controlled, 28-day safety study. Ann Allergy Asthma Immunol (2007) 0.85
The Role of Bronchodilators in Preventing Exacerbations of Chronic Obstructive Pulmonary Disease. Tuberc Respir Dis (Seoul) (2016) 0.85
Neutrophilic inflammation in induced sputum of patients with idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis (2003) 0.84
Indacaterol, a novel inhaled, once-daily, long-acting beta2-agonist for the treatment of obstructive airways diseases. Adv Ther (2009) 0.82
Pharmacokinetics and safety of aclidinium bromide in younger and elderly patients with chronic obstructive pulmonary disease. Int J Clin Pharmacol Ther (2012) 0.80
Tolerability and pharmacokinetics of inhaled bimosiamose disodium in healthy males. Br J Clin Pharmacol (2006) 0.78
Discrepant nasal and bronchial nitric oxide kinetics during early and late phase allergic reactions. Respir Med (2005) 0.78
Longitudinal measurement of airway inflammation over one year in children and adults with intermittent asthma. BMC Res Notes (2014) 0.78
Effect of histamine and adenosine 5'-monophosphate provocation on sputum neutrophils and related mediators in atopic patients. Ann Allergy Asthma Immunol (2005) 0.77
Effects of piclamilast, a selective phosphodiesterase-4 inhibitor, on oxidative burst of sputum cells from mild asthmatics and stable COPD patients. Lung (2004) 0.77
Inhaled pan-selectin antagonist Bimosiamose attenuates airway inflammation in COPD. Pulm Pharmacol Ther (2012) 0.76
Early bronchodilator action of glycopyrronium versus tiotropium in moderate-to-severe COPD patients: a cross-over blinded randomized study (Symptoms and Pulmonary function in the moRnING). Int J Chron Obstruct Pulmon Dis (2016) 0.75
[Verbal patient information through nurses--a case of stroke patients]. Pflege (2004) 0.75
Vocational analysis of health care professions as a basis for innovative curricular planning. An analysis and prognosis of the development of the professional competencies of midwives--cornerstones of innovative curricula in tertiary education. Nurse Educ Today (2005) 0.75
[Conservative therapeutic procedures in urinary incontinence: nursing is more than supplying incontinence aids]. Pflege Z (2004) 0.75
[Coping strategies of children with asthma. Testing the applicability of the German version of the Schoolagers' Coping Strategies Inventory (SCSI)]. Pflege (2006) 0.75
[Problem oriented learning with new media: The "Meducare" Project]. Pflege Z (2005) 0.75
[How children with bronchial asthma cope with their disease]. Kinderkrankenschwester (2005) 0.75
[The 1st graduate education days within the scope of the transfer project "nursing education and counseling in home nursing of sick children in Berlin]. Kinderkrankenschwester (2003) 0.75
[Study nurses in Germany--a survey of job-related activities in clinical trials as a basis for a job description and for training curricula]. Pflege (2007) 0.75
["Counselling" in nursing--an analysis of determining characteristics]. Pflege Z (2005) 0.75
[Patient and family oriented information and counseling in "home nursing of sick children" in Germany--a stepchild in scientific nursing research?]. Pflege (2003) 0.75